Takeda Pharmaceutical Company on Thursday, June 6, lost a bid to disqualify Baker Botts from representing generic drug company Zydus Pharmaceuticals in a lawsuit accusing Takeda of an antitrust violation.
Affirming a magistrate judge, US District Judge Freda Wolfson in Trenton, New Jersey, rejected Takeda’s argument that it had an implied attorney-client relationship with Baker Botts because of the firm’s previous representation of Takeda’s co-plaintiff in related patent litigation.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 216.73.216.118
Please verify email or join us
to access premium content!
